FDA to Hold Joint Meeting of Psychopharmacologic Drugs Advisory Committee and Pediatric Advisory Committee, Amends Notice

Summary

The US Food and Drug Administration (FDA) will convene a joint meeting of its Psychopharmacologic Drugs Advisory Committee and Pediatric Advisory Committee to revise a previously issued notice, according to a recent announcement on the FDA website (https://www.fda.gov/news-events/fda-announcements/joint-meeting-psychopharmacologic-drugs-advisory-committee-and-pediatric-advisory-committee-amendment-notice).